No profile data available.
GSK plc (GSK) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in London, United Kingdom, with about 66,841 full-time employees.
It reported revenue of 32.67 billion GBP for fiscal year 2025, up 4.1% from fiscal year 2024, and net income of 5.72 billion GBP. In Q2 2026 (the quarter ended June 30, 2026) revenue was 8.41 billion GBP, up 5.3% from a year before. United States was its largest region in fiscal year 2025, with 52% of revenue. Its market capitalization was $93.16 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments.
GSK reported 32.67 billion GBP in revenue for fiscal year 2025, up 4.1% from 31.38 billion GBP in fiscal year 2024. In Q2 2026 revenue was 8.41 billion GBP.
United States: 52% of revenue by region in fiscal year 2025, followed by International (25%).
$93.16 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Amgen Inc. (AMGN), Pfizer Inc. (PFE), Sanofi (SNY), Takeda Pharmaceutical Company Limited (TAK).